Clinical Trial

Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants

Recruiting
View on ClinicalTrials.gov →
Summary
This study will assess the effect of partially hydrolyzed, whey-based infant formulas on growth and gastrointestinal tolerance in healthy term infants.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-05-11; most recent amendment 2026-07-14.
Status change: Not Yet Recruiting → Recruiting 2023-10-05
Trial Details
NCT Number NCT05868408
Lead Sponsor Société des Produits Nestlé (SPN)
Conditions Infant Nutritional Physiological Phenomena, Infant Formula, Infant Health, Infant Development, Growth and Development
Enrollment 234 participants
Start Date 2023-08-17
Primary Completion 2027-12 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-15